{"count":220959,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1622","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1620","results":[{"created":"2020-09-01T12:53:25.943630+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4063","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col11a1 has been classified as Green List (High Evidence).","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T12:53:20.247300+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4063","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL11A1 were changed from  to Fibrochondrogenesis 1 (MIM#228520); Marshall syndrome (MIM#154780); Stickler syndrome, type II (MIM#604841)","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T12:52:59.174360+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4062","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: COL11A1 were set to ","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T12:52:31.200609+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4061","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: PRF1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 19487666; Phenotypes: Aplastic anemia 609135, Hemophagocytic lymphohistiocytosis, familial, 2 603553, Lymphoma, non-Hodgkin 605027; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PRF1","entity_type":"gene"},{"created":"2020-09-01T12:51:44.660532+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4061","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: COL11A1 was changed from  to Other","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T12:51:29.810501+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4060","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL11A1 was changed from Unknown to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T12:49:59.180136+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: HLCS: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 10190325; Phenotypes: Holocarboxylase synthetase deficiency, 253270; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"HLCS","entity_type":"gene"},{"created":"2020-09-01T12:48:19.884850+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: CA5A: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 26913920, 32381389; Phenotypes: Hyperammonemia due to carbonic anhydrase VA deficiency, 615751; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CA5A","entity_type":"gene"},{"created":"2020-09-01T11:23:59.931207+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: MOCS1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 21031595; Phenotypes: Molybdenum cofactor deficiency A 252150; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MOCS1","entity_type":"gene"},{"created":"2020-09-01T11:22:11.660169+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: KDM1A: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 29559475, 27094131; Phenotypes: Cleft palate, psychomotor retardation, and distinctive facial features 616728, Multiple myeloma; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","entity_name":"KDM1A","entity_type":"gene"},{"created":"2020-09-01T10:48:51.400120+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: COL11A1: Rating: GREEN; Mode of pathogenicity: Other; Publications: PMID 25073711, 30245514, 32427345, 27081569, 21035103; Phenotypes: Fibrochondrogenesis 1 (MIM#228520), Marshall syndrome (MIM#154780), Stickler syndrome, type II (MIM#604841), {Lumbar disc herniation, susceptibility to}, (MIM#603932), ?Deafness, autosomal dominant 37, (MIM#618533); Mode of inheritance: BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"COL11A1","entity_type":"gene"},{"created":"2020-09-01T09:26:39.548744+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.123","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GAS2L2 as Amber List (moderate evidence)","entity_name":"GAS2L2","entity_type":"gene"},{"created":"2020-09-01T09:26:39.538771+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.123","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gas2l2 has been classified as Amber List (Moderate Evidence).","entity_name":"GAS2L2","entity_type":"gene"},{"created":"2020-09-01T08:39:29.640511+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Tag founder tag was added to gene: GON7.","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T08:39:14.271055+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Tag founder tag was added to gene: GON7.","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T08:38:56.690101+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Zornitza Stark","item_type":"entity","text":"Tag founder tag was added to gene: GON7.","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T08:38:37.069595+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: YRDC as ready","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:37.060418+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:34.234089+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: YRDC as Green List (high evidence)","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:34.226186+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:32.071626+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: YRDC as ready","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:32.060468+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:24.372017+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: YRDC as Green List (high evidence)","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:24.363073+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:16.092015+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: YRDC as ready","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:38:16.082378+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:37:55.979755+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.248","user_name":"Zornitza Stark","item_type":"entity","text":"gene: YRDC was added\ngene: YRDC was added to Microcephaly. Sources: Literature\nMode of inheritance for gene: YRDC was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: YRDC were set to 31481669\nPhenotypes for gene: YRDC were set to Galloway-Mowat syndrome\nReview for gene: YRDC was set to GREEN\nAdded comment: Three individuals from two unrelated families with typical features of Galloway-Mowat syndrome including proteinuria, microcephaly, developmental delay and brain malformations. Supportive functional data. \nSources: Literature","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:37:52.081647+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: YRDC as Green List (high evidence)","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:37:52.072676+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4059","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: yrdc has been classified as Green List (High Evidence).","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:37:48.950389+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.129","user_name":"Zornitza Stark","item_type":"entity","text":"gene: YRDC was added\ngene: YRDC was added to Proteinuria. Sources: Literature\nMode of inheritance for gene: YRDC was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: YRDC were set to 31481669\nPhenotypes for gene: YRDC were set to Galloway-Mowat syndrome\nReview for gene: YRDC was set to GREEN\nAdded comment: Three individuals from two unrelated families with typical features of Galloway-Mowat syndrome including proteinuria, microcephaly, developmental delay and brain malformations. Supportive functional data. \nSources: Literature","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T08:36:52.686410+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4058","user_name":"Zornitza Stark","item_type":"entity","text":"gene: YRDC was added\ngene: YRDC was added to Mendeliome. Sources: Literature\nMode of inheritance for gene: YRDC was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: YRDC were set to 31481669\nPhenotypes for gene: YRDC were set to Galloway-Mowat syndrome\nReview for gene: YRDC was set to GREEN\nAdded comment: Three individuals from two unrelated families with typical features of Galloway-Mowat syndrome including proteinuria, microcephaly, developmental delay and brain malformations. Supportive functional data. \nSources: Literature","entity_name":"YRDC","entity_type":"gene"},{"created":"2020-09-01T07:06:40.539126+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4057","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GON7 as ready","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:06:40.527328+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4057","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:06:33.955979+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4057","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GON7 as Green List (high evidence)","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:06:33.947949+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4057","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:06:19.124247+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4056","user_name":"Zornitza Stark","item_type":"entity","text":"gene: GON7 was added\ngene: GON7 was added to Mendeliome. Sources: Literature\nMode of inheritance for gene: GON7 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: GON7 were set to 31481669\nPhenotypes for gene: GON7 were set to Galloway-Mowat syndrome\nReview for gene: GON7 was set to GREEN\nAdded comment: 11 individuals from 5 families. Four of the families had the same homozygous variant, shared haplotype suggestive of founder effect. Clinical features included proteinuria, microcephaly, brain malformations and developmental delay. Supportive functional data. \nSources: Literature","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:04:55.145703+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GON7 as ready","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:04:55.135589+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:04:50.673731+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GON7 as Green List (high evidence)","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:04:50.663895+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:04:23.797154+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"gene: GON7 was added\ngene: GON7 was added to Microcephaly. Sources: Literature\nMode of inheritance for gene: GON7 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: GON7 were set to 31481669\nPhenotypes for gene: GON7 were set to Galloway-Mowat syndrome\nReview for gene: GON7 was set to GREEN\nAdded comment: 11 individuals from 5 families. Four of the families had the same homozygous variant, shared haplotype suggestive of founder effect. Clinical features included proteinuria, microcephaly, brain malformations and developmental delay. Supportive functional data. \nSources: Literature","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:03:59.351670+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.128","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GON7 as ready","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:03:59.331326+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.128","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:03:37.960838+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.128","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GON7 as Green List (high evidence)","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:03:37.950844+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.128","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gon7 has been classified as Green List (High Evidence).","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T07:02:12.232616+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.127","user_name":"Zornitza Stark","item_type":"entity","text":"gene: GON7 was added\ngene: GON7 was added to Proteinuria. Sources: Literature\nMode of inheritance for gene: GON7 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: GON7 were set to 31481669\nPhenotypes for gene: GON7 were set to Galloway-Mowat syndrome\nReview for gene: GON7 was set to GREEN\nAdded comment: 11 individuals from 5 families. Four of the families had the same homozygous variant, shared haplotype suggestive of founder effect. Clinical features included proteinuria, microcephaly, brain malformations and developmental delay. Supportive functional data. \nSources: Literature","entity_name":"GON7","entity_type":"gene"},{"created":"2020-09-01T06:56:52.147340+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.126","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LAGE3 as ready","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:56:52.137075+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.126","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lage3 has been classified as Green List (High Evidence).","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:56:50.060383+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.126","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LAGE3 were changed from  to Galloway-Mowat syndrome 2, X-linked, MIM# 301006","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:56:23.410927+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.125","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LAGE3 were set to ","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:55:58.061728+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.124","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LAGE3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:55:33.945954+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.123","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LAGE3: Rating: GREEN; Mode of pathogenicity: None; Publications: 28805828; Phenotypes: Galloway-Mowat syndrome 2, X-linked, MIM# 301006; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:54:49.701746+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4055","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LAGE3 as ready","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:54:49.691077+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4055","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lage3 has been classified as Green List (High Evidence).","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:54:43.066454+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4055","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LAGE3 were changed from  to Galloway-Mowat syndrome 2, X-linked, MIM# 301006","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:54:24.610100+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4054","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LAGE3 were set to ","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:54:08.349579+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4053","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LAGE3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:53:48.091972+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4052","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LAGE3: Rating: GREEN; Mode of pathogenicity: None; Publications: 28805828; Phenotypes: Galloway-Mowat syndrome 2, X-linked, MIM# 301006; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:52:46.691437+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.245","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LAGE3 as ready","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:52:46.681099+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.245","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lage3 has been classified as Green List (High Evidence).","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:52:43.523778+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.245","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LAGE3 were changed from  to Galloway-Mowat syndrome 2, X-linked, MIM# 301006","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:52:26.266780+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.244","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LAGE3 were set to ","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:52:01.330214+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.243","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LAGE3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:51:29.910673+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.242","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LAGE3: Rating: GREEN; Mode of pathogenicity: None; Publications: 28805828; Phenotypes: Galloway-Mowat syndrome 2, X-linked, MIM# 301006; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"LAGE3","entity_type":"gene"},{"created":"2020-09-01T06:48:15.682916+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4052","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LINGO1 as ready","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:48:15.664317+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4052","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lingo1 has been classified as Amber List (Moderate Evidence).","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:48:09.522148+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4052","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LINGO1 were changed from  to Mental retardation, autosomal recessive 64, MIM# 618103","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:47:52.513523+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4051","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LINGO1 were set to ","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:47:36.473293+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4050","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LINGO1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:47:21.666748+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4049","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: LINGO1 as Amber List (moderate evidence)","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:47:21.653946+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4049","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lingo1 has been classified as Amber List (Moderate Evidence).","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:46:53.100671+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4048","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LINGO1: Rating: AMBER; Mode of pathogenicity: None; Publications: 31668702; Phenotypes: Mental retardation, autosomal recessive 64, MIM# 618103; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:45:47.333432+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.242","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LINGO1 as ready","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:45:47.323596+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.242","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lingo1 has been classified as Amber List (Moderate Evidence).","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:45:44.785149+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.242","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LINGO1 were changed from  to Mental retardation, autosomal recessive 64, MIM# 618103","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:45:19.591975+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.241","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LINGO1 were set to ","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:44:56.213126+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.240","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LINGO1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:44:34.768797+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.239","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: LINGO1 as Amber List (moderate evidence)","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:44:34.757763+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.239","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lingo1 has been classified as Amber List (Moderate Evidence).","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:44:03.240522+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.238","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: LINGO1: Changed rating: AMBER","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-09-01T06:43:56.893866+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.238","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LINGO1: Rating: ; Mode of pathogenicity: None; Publications: 31668702; Phenotypes: Mental retardation, autosomal recessive 64, MIM# 618103; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LINGO1","entity_type":"gene"},{"created":"2020-08-31T23:28:58.170662+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.123","user_name":"Tiong Tan","item_type":"entity","text":"Marked gene: TRIM8 as ready","entity_name":"TRIM8","entity_type":"gene"},{"created":"2020-08-31T23:28:58.160359+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.123","user_name":"Tiong Tan","item_type":"entity","text":"Gene: trim8 has been classified as Green List (High Evidence).","entity_name":"TRIM8","entity_type":"gene"},{"created":"2020-08-31T23:28:52.681659+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.123","user_name":"Tiong Tan","item_type":"entity","text":"Classified gene: TRIM8 as Green List (high evidence)","entity_name":"TRIM8","entity_type":"gene"},{"created":"2020-08-31T23:28:52.673193+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.123","user_name":"Tiong Tan","item_type":"entity","text":"Gene: trim8 has been classified as Green List (High Evidence).","entity_name":"TRIM8","entity_type":"gene"},{"created":"2020-08-31T23:28:04.825352+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.122","user_name":"Tiong Tan","item_type":"entity","text":"gene: TRIM8 was added\ngene: TRIM8 was added to Proteinuria. Sources: Literature\nMode of inheritance for gene: TRIM8 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: TRIM8 were set to 30244534; 32193649\nPhenotypes for gene: TRIM8 were set to intellectual disability; epileptic encephalopathy; nephrotic syndrome; proteinuria\nPenetrance for gene: TRIM8 were set to Complete\nReview for gene: TRIM8 was set to GREEN\nAdded comment: ~50% affected individuals have proteinuria, one confirmed with FSGS \nSources: Literature","entity_name":"TRIM8","entity_type":"gene"},{"created":"2020-08-31T22:10:00.887535+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OSGEP as ready","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:10:00.878890+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: osgep has been classified as Green List (High Evidence).","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:09:57.129514+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OSGEP were changed from  to Galloway-Mowat syndrome 3, MIM# 617729","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:09:38.720065+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.120","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: OSGEP were set to ","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:09:11.299767+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: OSGEP was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:46.894142+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OSGEP: Rating: GREEN; Mode of pathogenicity: None; Publications: 28805828, 28272532; Phenotypes: Galloway-Mowat syndrome 3, MIM# 617729; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:37.803412+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.238","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OSGEP as ready","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:37.795164+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"0.238","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: osgep has been classified as Green List (High Evidence).","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:08.407829+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4048","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OSGEP as ready","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:08.397460+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4048","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: osgep has been classified as Green List (High Evidence).","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:08:02.392185+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4048","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OSGEP were changed from  to Galloway-Mowat syndrome 3, MIM# 617729","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:07:46.597580+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4047","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: OSGEP were set to ","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:07:29.382462+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4046","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: OSGEP was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"OSGEP","entity_type":"gene"},{"created":"2020-08-31T22:07:14.308256+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.4045","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OSGEP: Rating: GREEN; Mode of pathogenicity: None; Publications: 28805828, 28272532; Phenotypes: Galloway-Mowat syndrome 3, MIM# 617729; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"OSGEP","entity_type":"gene"}]}